Short description
ImStar Therapeutics is a biotech company that develops treatments for patients with amyotrophic lateral sclerosis.
Description
ImStar Therapeutics is a biotech company that develops treatments for patients with amyotrophic lateral sclerosis. Its product pipeline is comprised of IMS-088, a small-molecule compound designed to address immune system activation pathway involved in neurodegeneration; and TDP-43 Associated NF-kB Activation Inhibitors.ImStar Therapeutics was founded in 2012 and is based in Vancouver, Canada.
Last funding
Cannot Access
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Vancouver, British Columbia, Canada, North America
Founded on
January 1, 2012
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Noaccessforu, Blurry Noaccess, Absolutely Noaccess, Noaccess, No Way, Absolutely Noaccess
Sign in for full access
Founders
Daniel Wattier, Jean Pierre Julien